Genes like TTK show potential as significant targets reported in breast, bladder, and prostate cancers [52,53,54,55], warranting further investigation of TTK−192 (p = 0.04 in UCEC) as an intriguing hotspot. This evidence concerns the gene TTK and Familial prostate cancer.